Johnson
Beyond's analysis on Johnson
- — Johnson & Johnson's equity portfolio reveals its top‑performing holdings among 15 stake investments
- — J&J’s $5.5 billion talc settlement removes a major overhang but leaves lingering legal risk for the healthcare conglomerate
- — Johnson & Johnson agrees to $5.5 billion settlement to resolve talc‑related lawsuits
- — Johnson & Johnson proposes a $5.5 billion settlement to end years of talc baby‑powder cancer lawsuits
- — Johnson & Johnson’s $5.5 billion talc settlement removes a major earnings overhang and sets a precedent for mass‑tort resolutions in consumer health
- — Johnson & Johnson proposes up to $5.5 billion settlement to resolve talc‑based baby‑powder cancer lawsuits
- — Johnson & Johnson's strong earnings raise the question of whether the stock remains a buying opportunity
- — Healthcare stocks become a safe haven as investors exit tech
- — Johnson & Johnson's share price rose sharply on Friday driven by company‑specific news and supportive market conditions
Recent news mentioning Johnson
- — Which Defensive Stock Has Dominated in 2026: Coca-Cola, Johnson & Johnson, or Procter & Gamble?
- — Is Johnson & Johnson Stock Priced For More Growth Than It Has Guided?
- — Atreon Orthopedics® Adds Darin Johnson to Board of Directors
- — Why Procter & Gamble’s Quieter Dividend Outpaces Johnson & Johnson’s Growth Story
- — The Inner Circle acknowledges Kate Johnson as a Trusted Realtor
- — Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch.
- — AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?
- — Johnson & Johnson Stock: Is JNJ Outperforming the Consumer Staples Sector?
- — Johnson & Johnson (JNJ) Taps Sail Biomedicines in Bid for CAR-T Edge Over Bristol Myers Squibb
- — Forget Nvidia. Johnson & Johnson and 2 Other AI Stocks Are Beating the Market by 29 Points.
- — Johnson & Johnson (NYSE:JNJ) Has A Better Balance Sheet Than The Government, Said Jim Cramer
- — Forrestania awards $104m Johnson Range mining contract to MEGA